Ipca Laboratories (+5.2%) reported Q2 FY20 results. PAT was up 63.3% y/y to 193.5 crore. Revenue grew 26.9% y/y to 1,284 crore. EBITDA was up 52.5% as the margin improved 350bps y/y to 20.7%.
Feedback
IPCALAB 
Reputation: 29,954 • Nov 7, 2019 11:43 PM
Vote
Comment
Share